ConductScience.org, home

Paper41394151

Part 1 - imidazolines and the changing face of nasal decongestants.

Stinson RJ and 1 other. Front Pharmacol, 2025. Cited by 1 paper, by iCite.

Cite this record

ConductScience Library. Part 1 - imidazolines and the changing face of nasal decongestants. Papers, record 41394151. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41394151

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Part 1 - imidazolines and the changing face of nasal decongestants.
PubMed
Journal
Front Pharmacol
PubMed
Year
2025
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
1
iCite
Revised in PubMed
2025-12-17
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Stinson RJRebecca J
2Sadofsky LRLaura R

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References131

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
132466864Using pictures to convey health information: A systematic review and meta-analysis of the effects on patient and consumer health behaviors and outcomes.Patient Educ Couns2020https://conductscience.org/library/papers/32466864PubMed
234355529The selectivity of α-adrenoceptor agonists for the human α1A, α1B, and α1D-adrenoceptors.Pharmacol Res Perspect2021https://conductscience.org/library/papers/34355529PubMed
340580050Revisiting Rhinitis Medicamentosa: Examining the Evidence on Topical Nasal Decongestants.J Pharm Pract2026https://conductscience.org/library/papers/40580050PubMed
438188313Naphazoline intoxication with transient QT prolongation and acute myocardial injury.J Cardiol Cases2024https://conductscience.org/library/papers/38188313PubMed
539535583European Pharmaceutical Industry Medical Information: A Role to Play in the Provision of Medicine-Related Information to Patients.Pharmaceut Med2024https://conductscience.org/library/papers/39535583PubMed
630215971Epistaxis: Outpatient Management.Am Fam Physician2018https://conductscience.org/library/papers/30215971PubMed
717388561Theoretical assessment of naphazoline redoxchemistry and photochemistry.J Phys Chem B2007https://conductscience.org/library/papers/17388561PubMed
86104975Pharmacology of centrally acting hypotensive drugs.Br J Clin Pharmacol1980https://conductscience.org/library/papers/6104975PubMed
93513687Efficacy and safety of topical oxymetazoline in treating allergic and environmental conjunctivitis.Ann Ophthalmol1986https://conductscience.org/library/papers/3513687PubMed
10241844Alpha adrenergic and histaminergic effects of tolazoline-like imidazolines.J Pharmacol Exp Ther1975https://conductscience.org/library/papers/241844PubMed
1120016692Treating rhinitis in the older population: special considerations.Allergy Asthma Clin Immunol2009https://conductscience.org/library/papers/20016692PubMed
122671220Nasal decongestant effect of oxymetazoline in the common cold: an objective dose-response study in 106 patients.J Laryngol Otol1989https://conductscience.org/library/papers/2671220PubMed
136154514Rhinitis medicamentosa.Can Med Assoc J1980https://conductscience.org/library/papers/6154514PubMed
146289955Receptor interactions of imidazolines: alpha-adrenoceptors of rat and rabbit aortae differentiated by relative potencies, affinities and efficacies of imidazoline agonists.Br J Pharmacol1982https://conductscience.org/library/papers/6289955PubMed
1535010673The Importance of Direct Patient Reporting of Adverse Drug Reactions in the Safety Monitoring Process.Int J Environ Res Public Health2021https://conductscience.org/library/papers/35010673PubMed
1631858187Myocardial infarction and ischemic stroke with vasoconstrictors used as nasal decongestant for common cold: a French pharmacovigilance survey.Eur J Clin Pharmacol2020https://conductscience.org/library/papers/31858187PubMed
1721313640The Use and Misuse of Drugs in Symptomatic Treatment of the Allergic Nose.Postgrad Med J1959https://conductscience.org/library/papers/21313640PubMed
1826065640Evaluating the Effect of Sinex® (0.05% Oxymetazoline) Nasal Spray on Reduction of Nasal Congestion Using Computational Fluid Dynamics.J Biomech Eng2015https://conductscience.org/library/papers/26065640PubMed
1911063925Autoradiographic comparison of [3H]-clonidine binding to non-adrenergic sites and alpha(2)-adrenergic receptors in human brain.Neuropsychopharmacology2000https://conductscience.org/library/papers/11063925PubMed
2039119149A historical perspective on clonidine as an alpha-2A receptor agonist in the treatment of addictive behaviors: Focus on opioid dependence.INNOSC Theranostics Pharmacol Sci2024https://conductscience.org/library/papers/39119149PubMed

See all 131 referencesDownload CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.

PMIDTitleJournalYearIn Papers
42331734Co(II), Cu(II), and Ni(II) Coordination Complexes: Synthesis, Characterization, Experimental, and Computational Study on Potential Antiplasmodial Activity.ChemMedChem2026https://conductscience.org/library/papers/42331734

Source PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41394151

GET https://conductscience.org/api/papers/v1/41394151/references?page=2